InternationalUSRemember you can easily switch between MIP US and MIP International at any time

Twenty cases that will change the way you work


Managing IP's cases of the year for 2012 includes the annual top 10, plus 10 smaller rulings you might have missed. By Emma Barraclough, Simon Crompton, Peter Leung, Paul Madill, Eileen McDermott, James Nurton and Alli Pyrah

This has not been a year for blockbuster cases. Even though the volume of litigation remains high, neither Europe nor Asia has thrown up many surprising results. And though the United States has given us Louboutin's red-soled shoes and the...


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain FREE access to up to five free articles when you register now.

Join here

profile

Managing IP

ManagingIP

ManagingIP profile

John Bochnovic, Executive Director of AIPPI, has resigned from the position (effective April 30, 2018) to return to… https://t.co/4dp8lsqg5Z

Feb 16 2018 04:19 ·  reply ·  retweet ·  favourite
ManagingIP profile

CAFC says 101 inquiry is a factual determination in “blockbuster” Berkheimer opinion https://t.co/wpYscoUhnY https://t.co/FPrkImTmGL

Feb 16 2018 03:13 ·  reply ·  retweet ·  favourite
ManagingIP profile

US falls to 12th in US Chamber patent ranking https://t.co/UP7AvAbZ4k Expect to hear this figure mentioned a lot at… https://t.co/gnWLDdISl2

Feb 15 2018 04:45 ·  reply ·  retweet ·  favourite
More from the Managing IP blog


null null null

null null null

February 2018

FRAND aid: Is the European Commission’s SEP guidance useful?

Both patent owners and implementers have welcomed the European Commission’s communication on standard essential patents. Does that mean it has successfully balanced competing interests or merely dodged the difficult questions? James Nurton investigates



Most read articles

Supplements